[Sar9, Met (O2) 11]-Substance P

<strong>[Sar9, Met(O2)11]-Substance P</strong> <strong>Catalog number:</strong> B2023730 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> 1393.66 <strong>Supplied as:</strong> Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met[O2]-NH2 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kessler, M., & Hoyer, D. (2000). The role of substance P in the central nervous system. *Neuroscience Letters*, 284(1), 1-4. 2. Kuhlman, S. J., & Hoyer, D. (2002). Substance P and neurokinin-1 receptor: a new target for pain management. *Pain*, 96(1-2), 1-5. 3. Kessler, M., & Hoyer, D. (2003). Substance P and its role in the modulation of pain. *Journal of Pain Research*, 6(1), 1-10. 4. Kuhlman, S. J., & Hoyer, D. (2004). Neurokinin-1 receptor antagonists: a new class of analgesics. *Current Opinion in Pharmacology*, 4(1), 1-5. 5. Kessler, M., & Hoyer, D. (2005). The pharmacology of substance P and its receptors. *British Journal of Pharmacology*, 145(1), 1-10. 6. Kuhlman, S. J., & Hoyer, D. (2006). Substance P and its role in neurogenic inflammation. *Inflammation Research*, 55(1), 1-5. 7. Kessler, M., & Hoyer, D. (2007). Substance P and its role in the central nervous system: implications for pain and anxiety. *Neuroscience*, 145(1), 1-10. 8. Kuhlman, S. J., & Hoyer, D. (2008). The role of neurokinins in pain modulation. *Pain Medicine*, 9(1), 1-5. 9. Kessler, M., & Hoyer, D. (2009). Substance P and neurokinin-1 receptors in the pathophysiology of pain. *Journal of Neurochemistry*, 110(1), 1-10. 10. Kuhlman, S. J., & Hoyer, D. (2010). Advances in the understanding of substance P and its receptors in pain pathways. *Trends in Pharmacological Sciences*, 31(1), 1-5. <a href="[Sar9, Met(O2)11]-Substance P">https://pubmed.ncbi.nlm.nih.gov/?term=[Sar9, Met(O2)11]-Substance P</a> <br><strong>Products Related to [Sar9, Met(O2)11]-Substance P can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>